STEPHANIE SALZER: Open Payments
NPI 1245935501 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,942 in 109 payments from 22 companies in 2025. Trend: 2023 $325 · 2024 $1,912 · 2025 $1,942
Food & beverage: $1,942
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $430 |
| ARGENX US, INC. | 9 | $241 |
| PFIZER INC. | 13 | $227 |
| Novartis Pharmaceuticals Corporation | 12 | $198 |
| UCB, Inc. | 7 | $176 |
| Lilly USA, LLC | 8 | $148 |
| ACADIA Pharmaceuticals Inc | 5 | $80 |
| Eisai Inc. | 4 | $79 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Biogen, Inc. | 2 | $45 |
Products named: VYVGART HYTRULO, NURTEC ODT, KESIMPTA, QULIPTA, AMYVID, UBRELVY, BOTOX, NUPLAZID.
Industry payments across LA — which companies pay providers there.
